Muvalaplin
Intervention3 papers1 findingPubChem 155369486
Outcomes
1Lipoprotein
downin humans1Low certainty
1 study
Lipoprotein
downin humans1Low certainty
Muvalaplin decreases lipoprotein in humans.
ReviewEarly-phase studies
Efficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic review · Journal of clinical lipidology · 26 Aug 2026
Latest
4Journal of Clinical LipidologyReview
Efficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic review
Methodist DeBakey Cardiovascular JournalReview
Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention
Journal of Atherosclerosis and ThrombosisReview
Lipoprotein(a) in Japan: An Expert Consensus Statement
American Journal of Cardiovascular DrugsReview